The crucial role of glucocorticoids in obesity and insulin resistance and the actions of the OB protein leptin on the hypothalamic-pituitary-adrenal (HPA) axis suggest that there is an important interaction of leptin with the glucocorticoid system. Therefore, we designed a study to test the effect of leptin directly on adrenocortical steroidogenesis. Primary cultures of bovine adrenocortical cells were incubated with increasing concentrations (10-1,000 ng/ml) of recombinant mouse leptin for 24 h, and the effects of leptin on basal and ACTH-stimulated cortisol secretion were determined. The accumulation of P450 17a mRNA following incubation with ACTH (10 nmol/1) and leptin (10-1,000 ng/ml) was analyzed by Northern blot. Adrenocortical cells were characterized by immunohistochemical staining for 17a-hydroxyprogesterone. Leptin (10-1,000 ng/ml) inhibited basal and ACTHstimulated cortisol release. At a concentration that occurs in obese individuals in vivo (100 ng/ml), it reduced basal cortisol secretion to 52.7 ± 37% (mean ± SE). The rise in cortisol secretion following maximal ACTH stimulation (10 nmol/1) was blunted to 55.2 ± 27%. At more physiological concentrations of ACTH (0.1 nmol/1), the inhibition of cortisol release by coincubation with low doses of leptin (10 ng/ml) was even more pronounced, leading to a reduction to 32.8% (1,248 ± 134 vs. 410 ± 157 nmol/1). Addition of OB protein (10-1,000 ng/ml) led to a dose-dependent reduction of ACTH-stimulated cytochrome P450 17a mRNA accumulation (from 80 to 45%), suggesting that leptin regulates adrenal steroidogenesis at the transcriptional level. These data clearly demonstrate that leptin inhibits cortisol production in adrenocortical cells and therefore appears to be a metabolic signal that directly acts on the adrenal gland.
A drenal glucocorticoid production plays a fundamental role in obesity and insulin resistance, and hypercortisolism is common in genetically obese fa/fa rats and db/db and ob/ob mice as well as obese humans with insulin resistance (1) (2) (3) (4) . Adrenalectomy reduces or prevents the metabolic changes in obese animal models (5, 6) .
Leptin, a protein secreted by adipocytes (7), is an adipostatic hormone that decreases food intake and body weight in obese and lean animals (8) . There is a clear reciprocal relationship between leptin and corticosterone levels, and leptin appears to be involved in the regulation of the diurnal pattern of corticosterone secretion (9) . In addition, administration of leptin reduces corticosterone levels in ob/ob mice (10) .
It is well established that leptin acts at the level of the hypothalamus (11) (12) (13) . However, recent studies suggest additional important peripheral actions of leptin involving both modulation of insulin action on liver cells (14) and production of steroid in the ovary (15) . hi the light of these data, when considering the crucial role of the adrenal in obesity and insulin resistance, the question arises whether leptin can directly influence adrenal glucocorticoid production. Therefore, we designed a study to test the direct effect of leptin on adrenocortical steroid production. A dose-dependent effect of leptin concentration on basal and ACTH-stimulated cortisol release in isolated bovine adrenocortical cells was investigated. A possible long-term effect of leptin on the accumulation of cytochrome P450 enzyme 17a-hydroxylase was investigated by Northern blot analysis.
RESEARCH DESIGN AND METHODS
Reagents. Unless otherwise indicated, all reagents were purchased from Sigma (Munich, Germany). Recombinant murine leptin was obtained from PeproTech (London, U.K.). Cell preparation, cell culture, and stimulation. Bovine adrenal glands were obtained from freshly slaughtered 8-to 15-month-old steer and were isolated as previously reported (16) . The cells were seeded on 24-well plates (200,000 cells per well) for cortisol measurement, on chamber slides (Nunc; 50,000 cells per well) for immunohistochemistry, and on 6-well plates (10 6 cells per well) for RNA isolation. The medium was replaced every 24-48 h. Experiments were performed after confluency reached at least 80%, after 3-4 days. The cells were washed and incubated for 24 h with serum-free medium containing ascorbic acid (10~7 mol/1), transferrin (0.001% wt/vol), and bacitracin (0.01% wt/vol). For measurement of cortisol, supernatants were removed and kept frozen at -20°C until assayed. Radioimmunoassay. Cortisol concentrations in the incubation media were measured by radioimmunoassay using a Biermann Cortisol-RIA kit (Bad Nauheim, Germany), which has a sensitivity of 5.5 nmol/1 and the following cross-reactivities: cortisol 100%, prednisolone 76%, 11-deoxycortisol 11.4%, prednisone 2.3%, and other steroids <1%. It has intra-and interassay variations of 5.1 and 6.4%, respectively. RNA isolation and Northern blot analysis. Total RNA was isolated from adrenocortical cells using the RNAzol B-RNA-isolation kit from AGS (Heidelberg, Germany). Electrophoresis and hybridization were performed as previously described (17) . Hybridization signals in the blots were normalized to the amount of 28S RNA on the nylon membrane and analyzed quantitatively by densitometric scanning. Immunohistochemistry. Immunostaining was performed by the avidinbiotin technique using the UniTect rabbit immunohistochemistry detection system (Dianova, Hamburg, Germany) as previously described (17) . Cells were incubated for 1 h at 37°C with a 1:10 dilution of the rabbit antiserum to 17a-hydroxyprogesterone (Sigma). Statistics. Treatments were administered in quadruplicate, and each experiment was repeated a minimum of three times. Data from the cell culture experiments are expressed as percentages of basal secretion (except in Fig. 2(7) , calculated as ratio of stimulated to basal cortisol levels for each experiment. Results were expressed as means ± SE, and statistical significance was determined by analysis of variance. P < 0.05 was considered significant.
RESULTS
Confluent monolayer cultures of bovine adrenocortical cells were characterized by immunohistochemical staining with an antibody against 17a-hydroxyprogesterone. There was no relevant contamination with chromaffin cells, fibroblasts, or other non-steroid-producing cells (Fig. 1 ). Cultures were incubated for 24 h with increasing doses of OB protein (leptin; 10-1,000 ng/ml). Basal rates of cortisol secretion decreased in a dose-dependent manner to 78.5 ± 12.2% at 10 ng/ml, 52.8 ± 37.2% at 100 ng/ml, and 25.3 ± 23.0% at 1,000 ng/ml ( Fig. 2A) . Basal cortisol levels (42 ± 26.4 nmol/1) were enhanced to 4,100% (1,738 ± 93.4 nmol/1) following a maximal stimulation with 10 nmol/1 ACTH. Leptin led to a dose-dependent (10-1,000 ng/ml) reduction of ACTH-stimulated cortisol release to 55.2 ± 27.1% (from 1,737 ± 208 to 958 ± 259 nmol/1) at 100 ng/ml leptin and to 47.6 ± 14.7% at 1,000 ng/ml (Fig. 2B) . At more physiological concentrations of ACTH (0.1 nmol/1), the inhibition from coincubation with OB protein (10 ng/ml) was even more pronounced: ACTH-stimulated cortisol release was reduced to 32.8 ± 12.6% (from 1,248 ± 134 to 410 ±158 nmol/1) (Fig. 2(7) . To see if leptin regulates steroidogenesis on the transcriptional level, the accumulation of P450 17a mRNA was analyzed by Northern blot (Fig. 3) . ACTH in a concentration of 10 nmol/1 led to a sixfold accumulation of P450 17a mRNA. Addition of leptin (10-1,000 ng/ml) led to a dose-dependent reduction (from 83 to 47%) of ACTH-stimulated P450 17a mRNA accumulation.
DISCUSSION
There is a well-established relationship between the nutritional status of mammals and the activity of the hypothalamic-pituitary-adrenal (HPA) axis (4, 18) . Leptin, a newly discovered adipostatic hormone (7), inhibits central appetite stimulation and regulates the HPA axis at the level of the hypothalamus (19) . In our study, we provide the first evidence that leptin can also act on the HPA axis peripherally at the level of the adrenal gland. Leptin at concentrations that occur in vivo led to a dose-dependent reduction of basal cortisol release from adrenocortical cells in primary culture. In addition, leptin blunted the ACTH-induced rise in cortisol release.
Elevated plasma cortisol levels are found in patients and animal models with obesity, glucose intolerance, and hyper- plasia of islets in the pancreas (1) (2) (3) 20) . Patients with Cushing's syndrome gain weight and have impaired glucose tolerance or develop secondary diabetes with insulin resistance (21) . Likewise, exogenous administration of glucocorticoids results in the metabolic characteristics of obesity, including hyperinsulinemia, p-cell hyperplasia, and insulin resistance (22, 23) . In addition, stroma cells in human adipose tissue develop the characteristic features of adipocytes after stimulation with glucocorticoids (24) . Adrenalectomy can partially normalize or prevent the weight gain and metabolic changes in obesity (8, 9, 11, 12) , and treatment of adrenalectomized animals with glucocorticoids results in reappearance of the obesity syndrome (5, 6, 25) . These facts highlight the crucial role of adrenal steroids in the development of obesity and insulin resistance, and it becomes clear that any factors involved in weight regulation will also influence adrenal steroid production. The inhibiting effects of leptin on neuropeptide Y (NPY) gene expression and secretion led to the proposal that NPY, a potent stimulator of feeding and of the HPA axis, was the major mediator of the actions of OB protein (10, 26) . However, mice totally deficient in NPY gene expression have normal body weight and respond well to leptin, suggesting that other important control mechanisms should exist (27) . Several arguments suggest that an inhibition of the HPA axis by leptin directly at the level of the adrenal gland, in addition to a central action, may be of physiological relevance. Confluent bovine adrenocortical cells were incubated with increasing doses of leptin (10-1,000 ng/ml) for 24 h. A: the basal rate (42 ± 26 nmol/1 = 100%) of cortisol secretion decreased in a dosedependent manner. B: leptin caused a dose-dependent (10-1,000 ng/ml) reduction of cortisol secretion after coincubation with 10 nmol/1 ACTH. C: incubation with increasing doses (0.01-10 nmol/1) of ACTH caused a dose-dependent increase in cortisol production, which was blunted by 10 ng/ml of leptin. Concentration of cortisol in the supernatants was determined by radioimmunoassay in quadruplicate samples from three to five different cell preparations. Results are expressed as means ± SE. *P 0.05 was considered significant.
First, we found that leptin concentrations that occur in vivo (28) decrease adrenocortical cortisol release. The adrenal gland itself is embedded in adipose tissue, and local concentrations of leptin may even be higher.
Second, our finding that leptin inhibits accumulation of P450 17a mRNA provides evidence for a long-term effect on Comparison of the effects of leptin (10-1,000 ng/ml) and ACTH (10 nmol/1) on the accumulation of mRNA encoding P450 17« enzyme. Total mRNA was isolated from adrenocortical cells after 24-h incubation with ACTH (A) and coincubation with ACTH and leptin: 10 ng/ml (5), 100 ng/ml (C), and 1,000 ng/ml (D). Blots were normalized to 28S and analyzed by densitometric scanning. Leptin reduced ACTH-stimulated accumulation of P450 17a mRNA from 80 to 45%. adrenal steroidogenesis. Although the rate-limiting step in steroid hormone biosynthesis is the side-chain cleavage of cholesterol (29) , 17a-hydroxylase is a major regulatory enzyme; P450 17a mRNA expression is regulated more rapidly and enzyme activity is increased more by ACTH than by other steroidogenic enzymes (30) . This may suggest that leptin regulates the HPA axis acutely at the level of the hypothalamus and that it chronically depresses steroidogenesis and the molecular expression of steroid enzymes at the level of the adrenal.
Third, diurnal variations in adrenal steroidogenesis do not seem to be directly related to plasma ACTH concentrations (31, 32) , whereas in rats a strict reciprocal diurnal relationship exists between leptin and corticosterone levels (9) . It will be interesting to see if leptin is responsible for this discrepancy, which possibly involves other identified pituitary or extrapituitary mechanisms that can influence adrenal steroidogenesis (33) (34) (35) .
A peripheral inhibition of glucocorticoids by leptin at the level of the adrenal gland is in accordance with the role of cor-ticotropin-releasing hormone (CRH) in weight regulation. On the one hand, CRH inhibits feeding in rodents (8, 36) and reduces weight and insulin levels. Since leptin increases CRH mRNA expression in the paraventricular nucleus of the hypothalamus, the activity of OB protein appears partly to be mediated through these increased CRH levels (8) . On the other hand, CRH is the major stimulator of the HPA axis and leads to the release of glucocorticoids, which have the opposite effects, resulting in weight gain and hyperinsulinemia. Therefore, a central activation of CRH and a peripheral glucocorticostatic action of leptin would be complementary to each other. In this context, it is of interest that adrenalectomy prevents the obesity syndrome produced by chronic central NPY infusion in normal rats and that the elevated CRH expression in these animals does not influence food intake, body weight gain, or insulinemia (37) . As predicted, it now becomes clear that a fundamental physiological function in the maintenance of energy balance appears to be regulated by a multidimensional system with overlapping control pathways (26) . The fact that leptin is a direct inhibitor of adrenal cortisol production is important for our understanding of both adrenal stress regulation and the role of the adrenal in metabolic diseases.
